Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Explore this article's sources with AI

ChatGPTClaudePerplexityGeminiGrokGoogle AI

Follow PeptideMethods on Google

First published

TB-500 and WADA: What Athletes Need

TB-500 is prohibited at all times under WADA's S2 growth-factor framework, including through named-example and related-substance wording.

Why we wrote this. Athletes need the exact rule and an enforcement example, not a vendor's interpretation of whether TB-500 is detectable.

In this article (6 sections)
  1. Where TB-500 sits on the list
  2. Named substances and related-substance rules
  3. USADA enforcement precedent
  4. What athletes should verify
  5. What the prohibited status does not prove
  6. What we do not know yet

TB-500 is prohibited at all times for athletes covered by the World Anti-Doping Code. USADA explains that thymosin beta-4 and its derivatives, including TB-500, were added as examples of prohibited growth factors under section S2.3[2]. At all times means both in competition and out of competition. The rule is about antidoping status, not whether a product has proven medical benefits.

The current USADA prohibited-list hub links the 2026 World Anti-Doping Agency list and directs athletes to Global DRO for medication checks[1]. TB-500 is also covered through the broader category of peptide hormones, growth factors, related substances and mimetics. Athletes should not assume that a substance is allowed merely because a brand name does not appear in a search result.

Where TB-500 sits on the list

Section S2 covers peptide hormones, growth factors, related substances and mimetics. A mimetic is a substance designed or claimed to imitate a biological signal. The list can give named examples while also covering other substances with similar biological effects or chemical structures. This catch-all structure prevents a slightly renamed or newly marketed compound from falling outside the rules by default.

USADA's summary of the 2018 changes states that thymosin beta-4 and its derivatives, for example TB-500, were added as examples of prohibited growth factors under S2.3[2]. That wording is useful because it addresses both the full-length molecule and derivative products rather than relying on one shop label.

The exact numbering and examples can change when a new annual list takes effect. The classification principle is more durable: athletes must check the list in force for the relevant date and ask their antidoping organization when a product identity is unclear.

A prohibited list is not a catalogue of every possible trade name. Some substances are named. Others are captured because they are derivatives, related substances or mimetics. For TB-500, the explicit historical wording is unusually clear, but the broader category still matters when a seller uses another label or does not disclose a full sequence.

Product ambiguity does not protect an athlete. Antidoping systems generally apply strict liability, meaning athletes are responsible for prohibited substances found in their samples, subject to the rules governing the case. A vendor's claim that a vial is for research only, natural or not on a label does not override the prohibited list.

The molecular distinction still matters scientifically. The TB-500 peptide page explains that products called TB-500 are associated with a short thymosin beta-4 fragment and should not be treated as clinically equivalent to full-length thymosin beta-4. Antidoping rules can cover both even though the clinical evidence differs.

USADA enforcement precedent

In an official sanction announcement, USADA reported that triathlete Anthony McCauley possessed and used BPC-157 and TB-500 and promoted several prohibited substances. USADA classified TB-500 as a non-specified substance in the class of peptide hormones, growth factors, related substances and mimetics[3]. The case shows that TB-500 is not merely a theoretical list entry.

USADA stated that the use and possession of non-specified substances carries a default four-year sanction under the applicable rules, and that the substances in the case were prohibited at all times[3]. A specific sanction can depend on the code version, facts, evidence and adjudication. Readers should not use one case to predict the exact outcome of another.

What athletes should verify

Check the list for the relevant year, not an old screenshot. Search every medication through the official tool recommended by your national antidoping organization. Supplements and unapproved injectables require extra caution because their labels may be incomplete or inaccurate. Global DRO is designed for approved medications in participating countries and cannot authenticate a grey-market vial.

A therapeutic use exemption, or TUE, is a formal route for a medically necessary prohibited treatment when the criteria are met. It is not a retrospective permission slip for self-directed use. An athlete who has a legitimate medical need should work with a clinician and antidoping organization before treatment whenever the rules require advance approval.

Country medicine law is a separate question. Our Denmark regulation overview covers the distinction between medicine regulation and sport rules. A product can be unapproved and prohibited, approved but prohibited in sport, or allowed medically under conditions while still requiring a TUE for competition.

What the prohibited status does not prove

WADA status does not establish that TB-500 heals injuries, and it does not validate the contents of products sold online. Antidoping rules are designed to protect fair competition and athlete health under the Code. Clinical approval requires a different evidence process involving quality, safety and efficacy.

A negative test also cannot make a product permissible. Detection windows and laboratory methods evolve, while rule violations can involve use, attempted use, possession, trafficking or complicity depending on the applicable code. Athletes should rely on the rule, not on claims about whether a substance is detectable.

What we do not know yet

A product sold as TB-500 may not disclose an exact sequence or may contain something else. That uncertainty can complicate both medical care and antidoping analysis. It does not convert the product into an allowed substance. Athletes should obtain case-specific advice from their national antidoping organization rather than relying on a vendor or forum interpretation.

The rule is direct: TB-500 is prohibited at all times under the S2 growth-factor framework. The annual list and the athlete's antidoping organization are the controlling references. Scientific uncertainty about what TB-500 does in humans is not a loophole in the rule.

Medical disclaimer: This article is for educational and journalistic purposes only and does not constitute medical advice. Peptides discussed may be classified as prescription medicines or research chemicals depending on your jurisdiction. Always consult a qualified healthcare professional before using any peptide product. PeptideMethods.com does not sell, distribute, or facilitate the sale of any peptide product.

Frequently asked

Is TB-500 banned by WADA?

Yes. TB-500 is prohibited at all times under the S2 framework for peptide hormones, growth factors, related substances and mimetics.

Is TB-500 prohibited outside competition?

Yes. Prohibited at all times includes both in-competition and out-of-competition periods.

Does TB-500 need to be named to be prohibited?

TB-500 has been named as an example, but the list also covers derivatives, related substances and mimetics. A missing trade name is not a safe-harbour.

Can an athlete get a TUE for TB-500?

A TUE requires a legitimate medical need and satisfaction of formal criteria. Athletes should contact their antidoping organization before treatment rather than assuming an unapproved product qualifies.

Sources

  1. [1]USADA: World Anti-Doping Agency Prohibited List, including the 2026 list and athlete guidanceTier 1 · primary↩
  2. [2]USADA: 2018 Prohibited List summary of major changes, naming thymosin beta-4 and TB-500 under S2.3Tier 1 · primary↩
  3. [3]USADA: Anthony McCauley accepts sanction for anti-doping rule violations involving TB-500Tier 1 · primary↩

No revisions yet. First published .

About the editorial team

PeptideMethods is written and edited by the PeptideMethods Editorial Team and published by Digital Compass Group Ltd. The team is not made up of medical professionals; every health, regulatory or dosage claim on the site is tied to a primary source and is not a substitute for advice from a qualified clinician.

See our editorial policy and methodology for how we research, source and verify.

Read the pillars